Clinical Trial Update: A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)

View source ↗

Summary

A completed clinical trial evaluating the safety of Rituxan (rituximab) in patients with rheumatoid arthritis who had an inadequate response to previous anti-TN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Status: COMPLETED